Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on developing treatments for gastrointestinal (GI) diseases, with a particular emphasis on GIMOTI^® (metoclopramide) nasal spray, together with EVERSANA, a leading provider of global commercial services to the life sciences industry,  announced the addition of Omnicell (NASDAQ: OMCL), a leader in medication management and fulfillment. This relationship is expected to expand patient access to GIMOTI, the only FDA-approved nasal spray for adults with acute and recurrent diabetic gastroparesis specifically, into large gastroenterology organizations.

As part of Evoke’s strategy to broaden GIMOTI’s reach through key pharmacy partnerships, the addition of Omnicell is meant to ensure better alignment with specialty pharmacies used by large gastroenterology group practices, like Gastro Health, which has a presence in 7 states and 150 locations. Omnicell manages a collection of these targeted pharmacies that specialize in GI products that are affiliated with large gastrointestinal physician organizations. This relationship is expected to almost double the number of specialty pharmacies available to access Gimoti.

“Adding Omnicell as a pharmacy manager is a direct reflection of the strategy we’ve shared publicly — to improve patient access by aligning with the specialty pharmacies GI physicians trust and use every day,” said Matt D’Onofrio, Chief Executive Officer of Evoke Pharma. “With support from EVERSANA and integration with Omnicell, we’re working to remove barriers for providers and help patients get the care they need faster.”

“Large GI practices are structured for scale and efficiency, and many have long-standing relationships with preferred specialty pharmacies,” said Chris Quesenberry, Chief Commercial Officer at Evoke Pharma. “Omnicell is an organization that understands the complexities of specialty care and offers turnkey solutions intended to optimize provider and patient experience. It’s another major step forward in making GIMOTI accessible in the real-world environments where patients are being treated.”

In a separate agreement, Evoke has also accessed Brentwood Pharmacy via a partnership agreement via Eversana. Brentwood is the specialty pharmacy affiliated with OneGI, another large gastroenterology network located in Tennessee, Kentucky, Ohio, Mississippi and other surrounding states. OneGI manages approximately 200 gastroenterologists and specialized physician assistants located at over 30 offices. This expansion further enables rapid delivery of GIMOTI and expands access to additional insurance plans for patients.